A Study Comparing GB241 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma

Trial Profile

A Study Comparing GB241 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma

Recruiting
Phase of Trial: Phase I

Latest Information Update: 29 Dec 2016

At a glance

  • Drugs Rituximab (Primary)
  • Indications Non-Hodgkin's lymphoma
  • Focus Pharmacokinetics
  • Sponsors Nanjing Yoko Biomedical
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 29 Dec 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top